Moreover, CD367 (DC immunoreceptor [DCIR]) has been repeatedly mentioned as a therapeutic target because it regulates immune tolerance to self and because autoimmune diseases developed in DCIRKO mouse models (16). This evidence concerns the gene CLEC4A and autoimmune disease.